Trilogy Capital
Trilogy Capital reported 401 stocks worth $2.6B in its 13F filing for Q3 2026, filed Oct 20, 2026. Its largest holdings are VTI (10.3%), QQQ (4.6%) and DLN (4.5%). Compared with Q2 2026, the fund opened new positions in AIPO, added to VTI, DLN and IVV, trimmed QQQ, IJR and XLK and sold out of URA, CINF and PAYX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  VTI Vanguard Total Stock Market ETF | $267M | 10.3% | 713K | +21K (+3%) | 8 of 8 | |
| 2 |  QQQ Invesco Qqq TR | $118M | 4.6% | 160K | −1,188 (−1%) | 8 of 8 | |
| 3 |  DLN Wisdomtree TR | $117M | 4.5% | 1.2M | +5,552 (+0%) | 7 of 8 | |
| 4 |  IVV Ishares TR | $117M | 4.5% | 152K | +1,502 (+1%) | 8 of 8 | |
| 5 |  SMTH Alps ETF TR | $111M | 4.3% | 4.5M | +320K (+8%) | 4 of 8 | |
| 6 |  VEA Vanguard Tax-Managed Fds | $75M | 2.9% | 1.1M | +15K (+1%) | 8 of 8 | |
| 7 |  EMMF Wisdomtree TR | $70.4M | 2.7% | 1.9M | +41K (+2%) | 8 of 8 | |
| 8 |  BND Vanguard BD Index Fds | $68.2M | 2.6% | 972K | +152K (+19%) | 8 of 8 | |
| 9 |  IJH Ishares TR | $50.5M | 1.9% | 702K | +28K (+4%) | 8 of 8 | |
| 10 |  SPMO Invesco S&P | $49.7M | 1.9% | 328K | +194K (+145%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 URA Global X Uranium ETF | $4.8M | 110K |
 CINF Cincinnati Finl Corp | $3.9M | 21K |
 PAYX Paychex Inc | $3.5M | 36K |
 ADBE Adobe Inc | $3.2M | 16K |
 JD Jd.com Inc | $3.1M | 123K |
🔒 Free account: see all 26.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 SPY Spdr S&P 500 ETF TR | Call | $4.1M | 5,400 | +1,200 |
 ASTS Ast Spacemobile Inc | Call | $3.2M | 55K | +54,500 |
 HALO Halozyme Therapeutics Inc | Put | $1.7M | 15K | +15,000 |
 GILD Gilead Sciences Inc | Call | $1.5M | 10K | +10,000 |
 XOM Exxon Mobil Corp | Put | $749K | 4,600 | +4,600 |
🔒 Free account: see all 8.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 20, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Trilogy Capital 13F FAQ
What does Trilogy Capital own?
Trilogy Capital reported 401 stocks worth $2.6B in its 13F filing for Q3 2026, filed Oct 20, 2026. Its largest holdings are VTI (10.3%), QQQ (4.6%) and DLN (4.5%). The table above lists every position in the filing (the top 10 without an account).
What did Trilogy Capital buy and sell in Q3 2026?
Compared with Q2 2026: 27 new positions, 215 added to, 125 trimmed and 26 sold out. New positions include AIPO. It sold all of URA, CINF and PAYX.
When will Trilogy Capital file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Trilogy Capital's portfolio worth?
The Q3 2026 filing reports $2.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.